New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
13:49 EDTRVBDSilver Peak confirms patent win against Riverbed, seeks permanent injunction
A Delaware jury delivered a verdict Tuesday in favor of Silver Peak in a trial in which Silver Peak asserted infringement of two of its patents against Riverbed. Silver Peak intends to seek a permanent injunction against the features of Riverbed’s RiOS and Steelhead devices covered by the Silver Peak patents – “SDR-Adaptive,” as well as “Enhanced Auto-Discovery” when used in combination with “Full Transparency.” The jury in the United States District Court for the District of Delaware found that one Silver Peak patent – U.S. Patent No. 7,945,736 – was directly infringed under the Doctrine of Equivalents and was also contributorily infringed by Riverbed. The validity of that patent was not challenged at trial. The jury also found that Riverbed induced infringement of a second Silver Peak patent – U.S. Patent No. 7,948,921 – and rejected an invalidity challenge to that patent. The court had previously granted summary judgment of direct infringement of that patent by Riverbed. Riverbed initiated the litigation in 2011. The asserted claims of two of the patents originally asserted by Riverbed were invalidated in inter partes reexamination before the United States Patent and Trademark Office, and Riverbed’s claims have been stayed by the court while those decisions are being appealed.
News For RVBD From The Last 14 Days
Check below for free stories on RVBD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent RVBD news | >>
July 24, 2014
16:18 EDTRVBDRiverbed reports Q2 adjusted EPS 26c, consensus 27c
Subscribe for More Information
July 18, 2014
11:34 EDTRVBDOptions with increasing implied volatility
Subscribe for More Information
08:38 EDTRVBDVerizon added to Triple Play list at Oppenheimer
Oppenheimer added Verizon (VZ) to its Triple Play list. The firm says its triple play stocks are rated Outperform, screen positively based on trends in earnings revisions and have an attractive technical profile. The firm removed Riverbed (RVBD) from the list after it downgraded that stock.
July 17, 2014
11:23 EDTRVBDOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTRVBDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:13 EDTRVBDElliiot says bought Riverbed shares, interested in raising stake but prevented
Subscribe for More Information
July 16, 2014
17:23 EDTRVBDRiverbed initiated with a Neutral at Buckingham
Subscribe for More Information
10:44 EDTRVBDOptions with increasing implied volatility: KORS TWX RVBD
Subscribe for More Information
July 15, 2014
10:48 EDTRVBDOptions with increasing implied volatility: GLUU KORS RVBD HSH
July 14, 2014
16:30 EDTRVBDOn The Fly: Closing Wrap
Subscribe for More Information
13:11 EDTRVBDRiverbed downgraded to Perform at Oppenheimer
Subscribe for More Information
13:06 EDTRVBDRiverbed downgraded to Perform from Outperform at Oppenheimer
Subscribe for More Information
12:21 EDTRVBDOn The Fly: Midday Wrap
Subscribe for More Information
10:59 EDTRVBDElliot reaffirms $21 Riverbed bid following Q2 warning
Subscribe for More Information
10:54 EDTRVBDRiverbed Q2 miss strengthens Elliot case, says Wells Fargo
Subscribe for More Information
10:02 EDTRVBDElliott Management reaffirms $21 per share cash bid for Riverbed
Subscribe for More Information
09:16 EDTRVBDOn The Fly: Pre-market Movers
HIGHER: Citigroup (C), up 3.6% after reporting better than expected Q2 results, announcing $7B settlement with DOJ and FDIC... Apple (AAPL), up 0.7% after Barclays upgrades stock to Overweight, Morgan Stanley raises Apple estimates above consensus... Shire (SHPG), up 1.6% after receiving revised proposal from AbbVie (ABBV) of GPB 53.20 per share, which it says it would be willing to recommend to Shire shareholders. AbbVie is down 2.8% after the news... Mylan (MYL), up 4% after acquiring Abbott's (ABT) non-U.S. developed markets specialty and branded generics business in all-stock transaction valued at about $5.3B. Abbott up 1.6% after the news... Progenics (PGNX), up 13% after FDA says RELISTOR can be approved on data submitted in sNDA... Exelixis (EXEL), up 13% after announcing coBRIM Phase 3 trial met primary endpoint... URS (URS) up 8% after acquired by AECOM Technology (ACM) for $56.31 per share. AECOM shares alos up 2% after deal announcement... Whiting Petroleum (WLL), up 4.5% after agreeing to acquire Kodiak Oil & Gas (KOG) in a $6B transaction. Kodiak Oil & Gas up 3%... Kandi Technologies (KNDI), up 11% after announcing JV's sale of 4,114 EVs in Q2. LOWER: Riverbed (RVBD), down 4.5% after saying it sees its Q2 adjusted EPS at low end of 26c-28c range... Harmonic (HLIT), down 13% after reporting preliminary Q2 earnings results.. EBay (EBAY), down 0.5% after downgraded at Pacific Crest, confirming partnership plans with Sotheby's (BID).
09:14 EDTRVBDRiverbed falls on Q2 EPS view, levels to watch
Subscribe for More Information
08:32 EDTRVBDRiverbed CEO says Q2 sales 'below expectations'
Subscribe for More Information
08:31 EDTRVBDRiverbed sees Q2 adjusted EPS at low end of 26c-28c range, consensus 27c
Cuts Q2 adjusted revenue view to $264M-$265M from $274M-$280M, consensus $277.42M. “Second quarter sales were below our expectations, principally in North America as we experienced longer sales cycles on some of our larger and more complex deals. We have carefully reviewed our opportunities and prospects for the remainder of the year and continue to have confidence in our ability to grow the business and deliver targeted earnings performance,” said Jerry M. Kennelly, chairman and CEO, Riverbed. “During the quarter, we continued to prudently manage expenses and focus on achieving operating leverage, as demonstrated by our solid EPS performance within our guided range.”
1 | 2 | all recent RVBD news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use